Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Jul 28 2026

· Issued by Alembic Pharmaceuticals Limited via NSE India

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 28, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets, 1 mg and 2 mg.".

View Attachment

Earlier from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases